KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Quest Diagnostics (DGX) Leases (2019 - 2025)

Quest Diagnostics (DGX) has disclosed Leases for 10 consecutive years, with $657.0 million as the latest value for Q4 2025.

  • Quarterly Leases rose 0.92% to $657.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $657.0 million through Dec 2025, up 0.92% year-over-year, with the annual reading at $657.0 million for FY2025, 0.92% up from the prior year.
  • Leases hit $657.0 million in Q4 2025 for Quest Diagnostics, up from $649.0 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $661.0 million in Q3 2024 to a low of $579.0 million in Q1 2024.
  • Historically, Leases has averaged $615.6 million across 5 years, with a median of $605.0 million in 2022.
  • Biggest five-year swings in Leases: increased 17.19% in 2021 and later dropped 5.0% in 2023.
  • Year by year, Leases stood at $597.0 million in 2021, then fell by 2.01% to $585.0 million in 2022, then grew by 2.91% to $602.0 million in 2023, then increased by 8.14% to $651.0 million in 2024, then increased by 0.92% to $657.0 million in 2025.
  • Business Quant data shows Leases for DGX at $657.0 million in Q4 2025, $649.0 million in Q3 2025, and $655.0 million in Q2 2025.